Pseudopheochromocytoma
- PMID: 31655774
- PMCID: PMC6903402
- DOI: 10.1016/j.ecl.2019.08.004
Pseudopheochromocytoma
Abstract
Pseudopheochromocytoma manifests as severe, symptomatic paroxysmal hypertension without significant elevation in catecholamine and metanephrine levels and lack of evidence of tumor in the adrenal gland. The clinical manifestations are similar but not identical to those in excess circulating catecholamines. The underlying symptomatic mechanism includes augmented cardiovascular responsiveness to catecholamines alongside heightened sympathetic nervous stimulation. The psychological characteristics are probably attributed to the component of repressed emotions related to a past traumatic episode or repressive coping style. Successful management can be achieved by strong collaboration between a hypertension specialist and a psychiatrist or psychologist with expertise in cognitive-behavioral panic management.
Keywords: Hypertension; Paroxysm; Pheochromocytoma; Pseudopheochromocytoma; Spell.
Copyright © 2019 Elsevier Inc. All rights reserved.
Figures
References
-
- Kuchel O Pseudopheochromocytoma. Hypertension 1985;7(1):151–158. - PubMed
-
- Kuchel O Increased plasma dopamine in patients presenting with the pseudopheochromocytoma quandary: retrospective analysis of 10 years’ experience. J Hypertens 1998;16(10):1531–1537. - PubMed
-
- Sharabi Y, Goldstein DS, Bentho O, et al. Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma. J Hypertens 2007;25(11):2286–2295. - PubMed
-
- Hall WD. Resistant hypertension, secondary hypertension, and hypertensive crises. Cardiol Clin 2002;20(2):281–289. - PubMed
-
- Page IH. A syndrome simulating diencephalic stimulation occuring in patients with essential hypertension Am J Med Sci 1935;190:9–14.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous